| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/26/2008 | US20080153694 Amorphous Silica Particles Having High Absorbing Capabilities and High Structural Characteristics |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080152738 Oil-in-water emulsions; agglutination; evaporation; lectin |
| 06/26/2008 | US20080152731 Compositions and method for hair loss prevention |
| 06/26/2008 | US20080152711 Compressible solid particles, procedures for the obtention thereof and procedures for the use of said particles in body-cleansing tablets |
| 06/26/2008 | US20080152708 Injectable, sucrose acetate isobutyrate solution easily formulated with therapeutic agents |
| 06/26/2008 | US20080152703 Epitopes formed by non-covalent association of conjugates |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152675 Sustained release of drug in an aqueous phase containing at least one amphiphilic polymer; dispersion in a continuous lipid phase; water in oil emulsions; low viscosity for injection; aspartate-glutamate or aspartic-glutamic copolymers; biodrugs |
| 06/26/2008 | US20080152668 Thymosin Alpha 1 Peptide/Polymer Conjugates |
| 06/26/2008 | US20080152667 Neurotoxin/immunoglobulin fusion for use in treatment and prevention of pain and respiratory system disorders |
| 06/26/2008 | US20080152615 Vaccine containing immunopotentiator; administering to animal together with antigen having low immunogenicity; side effect reduction; preventive or curative vaccine for non-contagious chronic diseases and cancers of bladder, brain, glioma, breasts, lungs, colons, ovaries, head, and neck; antitumor agents |
| 06/26/2008 | US20080152605 Cosmetic compositions comprising at least one starch and at least one peg fatty diester, and uses thereof |
| 06/26/2008 | US20080152597 Dermal penetration enhancers and drug delivery systems involving the same |
| 06/26/2008 | DE20122843U1 Fentanyl Zusammensetzung zur nasalen Anwendung Fentanyl composition for nasal administration |
| 06/26/2008 | DE112006002374T5 Antioxidans und Aromastoff in Lebensmittelqualität aus geröstetem Weizenmalz Antioxidant and flavoring in food quality toasted wheat |
| 06/26/2008 | DE102007036184A1 Composition, useful e.g. to reduce the formation of white residues on the cloth and skin, and as a thickener, emulsifier, thickener and stabilizer, comprises phosphoric acid ester, surfactant, electrolyte, hydrogen peroxide and water |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2672973A1 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | CA2672810A1 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | CA2672618A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | CA2671728A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/26/2008 | CA2671059A1 Ultra high performance clarified gellan gums |
| 06/26/2008 | CA2670453A1 Dispersion of polyamino acids in a continuous lipid phase |
| 06/26/2008 | CA2669921A1 Human monoclonal antibodies to btla and methods of use |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935434A1 Construction and use of transfection enhancer elements |
| 06/25/2008 | EP1935433A1 A method for preparing covalent lipid-spacer-peptide conjugates |
| 06/25/2008 | EP1935409A2 Synthetic platelets |
| 06/25/2008 | EP1935408A1 Device for the topical application of medical ozone for the treatment of oral cavity diseases |
| 06/25/2008 | EP1935407A1 Low viscosity liquid dosage forms |
| 06/25/2008 | EP1934289A2 Interpenetrating networks, and related methods and compositions |
| 06/25/2008 | EP1934138A2 Amphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 06/25/2008 | EP1933879A2 Bioconjugates comprising sulfated polysaccharides and their uses |
| 06/25/2008 | EP1933878A2 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| 06/25/2008 | EP1933877A2 Method of preparing a hydrogel |
| 06/25/2008 | EP1933876A1 Particulate lipid pharmaceutical composition |
| 06/25/2008 | EP1933875A2 Conjugates of photosensitisers and antibodies |
| 06/25/2008 | EP1933874A2 Targeted biocides |
| 06/25/2008 | EP1933858A1 A medical composition for treating wounds |
| 06/25/2008 | EP1933837A2 Liquid pharmaceutical compositions of nimodipine |
| 06/25/2008 | EP1933827A2 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 06/25/2008 | EP1933826A1 Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture |
| 06/25/2008 | EP1933809A2 Compositions for nasal delivery |
| 06/25/2008 | EP1933805A1 Anti-inflammatory compositions and methods of use |
| 06/25/2008 | EP1578841B1 Maleamic acid polymer derivatives and their bioconjugates |
| 06/25/2008 | EP1567578B1 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses |
| 06/25/2008 | EP1492499B1 Formoterol and mometasone aerosol formulations |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | EP1325034B1 Pharmaceutically acceptable starch and manufacturing process thereof |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | CN201076615Y Waterproof medicinal plaster |
| 06/25/2008 | CN101208090A Stabilized composition |
| 06/25/2008 | CN101208075A Liposome composition for induction of immunity |
| 06/25/2008 | CN101206944A Method of preparing bioavailability water-based magnetofluid |
| 06/25/2008 | CN101205302A Polyphosphate ester-polycaprolactone tri-block copolymer and uses thereof |
| 06/25/2008 | CN101205277A Carbomer ball milling modification method |
| 06/25/2008 | CN101204576A Process for preparing cerebroprotein hydrolysate NaCl injection |
| 06/25/2008 | CN101204450A Chinese traditional traditional medicine enema and preparation method thereof |
| 06/25/2008 | CN101204447A Anti-hepatitis-jaundice soft capsule and preparation method thereof |
| 06/25/2008 | CN101204446A Soft capsule containing medicine for acute and chronic hepatitis |
| 06/25/2008 | CN101204445A Soft capsule for hepatitis and preparation method thereof |
| 06/25/2008 | CN101204431A Chinese traditional medicine capsule for acne and splash and preparation method thereof |
| 06/25/2008 | CN101204415A Patch for treating sunstroke |
| 06/25/2008 | CN101204411A Baizhu volatile oil inclusion compound and preparation method thereof |
| 06/25/2008 | CN101204398A External nanometer titanium dioxide antiinflammatory agent |
| 06/25/2008 | CN101204397A 一种稳定的复方滴眼液 A stable compound eye drops |
| 06/25/2008 | CN101204396A Citicoline sodium dispersible tablets and preparation method thereof |
| 06/25/2008 | CN101204395A Orally disintegrating entecavir tablets |
| 06/25/2008 | CN101204394A Composite containing pioglitazone HCL and repaglinide |
| 06/25/2008 | CN101204393A Anethol trithione soft capsule and preparation method thereof |
| 06/25/2008 | CN101204392A Self-emulsifying microemulsion daidzein oral liquid preparation composite and preparation method thereof |
| 06/25/2008 | CN101204390A Paclitaxel mainline menstruum and application programme thereof |
| 06/25/2008 | CN101204389A Iatric composite containing Rivastigmine and preparation method thereof |
| 06/25/2008 | CN101204388A Application method of calcium polyenoic acid on medical treatment and cosmetology filed |
| 06/25/2008 | CN101204387A Novel tamsulosin hydrochloride sustained release capsules |
| 06/25/2008 | CN101204385A Child soluble amantadine hydrochloride troche |
| 06/25/2008 | CN101204384A Selective estrogen receptor modulator reducing lipide characteristic |
| 06/25/2008 | CN101204382A Mitomycin double sustained release film of implanted antineoplastic agents and its preparation method |
| 06/25/2008 | CN101204380A Sustained-release coated pellets for 24 hours |
| 06/25/2008 | CN101204377A Novel cryoprotectants prescription for treatment of botulinum toxin a freeze-dried powder and injection preparation |
| 06/25/2008 | CN101204376A Oxaliplatin freeze-dried powder and injection preparation method thereof |
| 06/25/2008 | CN101204374A Coating compound polyvalent high efficient yolk antibody |
| 06/25/2008 | CN101204373A Paclitaxel lipid microspheres injection and preparation method thereof |
| 06/25/2008 | CN101204370A Zolinza sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204369A Sorafenib sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204368A Pirarubicin sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204367A Axitinib sustained-release implplant treating for solid tumor |
| 06/25/2008 | CN101204366A Melphalan sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204365A Implant agent treating for solid tumor |
| 06/25/2008 | CN101204364A Delivery system and application of chitosan mucosa compromising mucosal adjuvant |
| 06/25/2008 | CN100396332C Quickly soluble film preparations |
| 06/25/2008 | CN100396331C Carrier particle latex for assay reagent and assay reagent |
| 06/25/2008 | CN100396290C External use anti-bacteria foaming agent for gynecology |
| 06/25/2008 | CN100396289C Scutellarin injection preparation and its preparing method |